Prevent Blindness America is leading the effort to secure federal funding for programs that prevent blindness and preserve sight.
The FDA Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of bepotastine besilate ophthalmic solution 1.5% (Bepreve, ISTA Pharmaceuticals) for treating ocular itching associated with allergic conjunctivitis.
A new device (TearLab Osmolarity System, TearLab Corp.) that measures the osmolarity of tears to aid in the diagnosis of dry eye disease has been given FDA 501(k) clearance and also has received a silver 2009 Medical Design Excellence Award (MDEA).
New spectral-domain optical coherence tomography technology allows visualization of the junction of the inner and outer segments of the photoreceptors. Assessment of the photoreceptor integrity line in eyes with and without disorders of the outer retina indicates it is a useful biomarker for photoreceptor impairment.
Optical coherence tomography (OCT) can be an effective diagnostic tool that enables optometrists to examine the retina layer by layer. It also can offer quantitative data about the retinal nerve fiber layer. Some doctors believe that the biggest advantage of OCT is what it reveals about the vitreomacular interface.
Switching patients to 1-day disposable contact lenses (CLs) may improve lens-wearing comfort for those who have seasonal allergic conjunctivitis, according to CooperVision.
Modern fluoroquinolones have evolved over more than 4 decades, from the parent quinolone compound, nalidixic acid (NegGram, Sanofi-Aventis US), patented in 1962. Since then, more than 10,000 derivatives have been patented, all with structural modifications that added features to improve systemic absorption, extend spectrum of action to include Gram-positive microorganisms, and reduce systemic toxicity.
Incorporating a system for the assessment, diagnosis, and management of glaucoma (Heidelberg Retina Tomograph 3, Heidelberg Engineering) in a clinical glaucoma and retinal practice enables the clinician to make better-informed decisions about what therapy to start or maintain to treat patients with either disease.
Every online purchase of any new pair of Maui Jim sunglasses from www.mauijim.com through July 31 will result in the donation of a pair of new Maui Jim sunglasses to Unite for Sight, a non-profit group that has as its goal improving eye health and eliminating preventable blindness among severely impoverished people.
Increasing market share for your practice includes an honest assessment of the benefits your practice brings to prospective patients. Consider their needs and preferences carefully to help you devise a value proposition that will make your practice their top choice.